Introduction to Penumbra Inc.

Penumbra Inc. is a world-renowned Healthcare company headquartered in Alameda, California, dedicated to developing and commercializing innovative medical devices that address unmet clinical needs in neurovascular and peripheral vascular disease. Founded in 2004, Penumbra has grown from a small start-up into a publicly traded corporation (NYSE: PEN) with a market capitalization exceeding $10 billion. The company employs approximately 3,000 professionals across manufacturing facilities in the United States, Europe, and Asia, serving over 80 countries worldwide. Penumbra’s reputation as a Healthcare innovation leader stems from its pioneering work in mechanical thrombectomy for acute ischemic stroke, a therapy that has transformed stroke care globally. The company’s flagship products include the Penumbra System, 3D Revascularization Device, and Indigo System for aspiration thrombectomy in peripheral vasculature. Penumbra is consistently recognized by Fortune and Forbes as one of America’s fastest-growing companies, and its commitment to quality is reflected in its ISO 13485 certification and FDA approvals. This Penumbra Inc. company profile provides an exhaustive overview for job seekers, investors, and industry analysts seeking to understand what makes Penumbra a top-tier Healthcare organization. Whether you are a clinician, engineer, or business professional, working at Penumbra means contributing to lifesaving innovations that improve patient outcomes. The company’s culture of engineering excellence, clinical rigor, and patient-centricity attracts top talent from around the globe. In the following sections, we explore Penumbra’s history, strategy, products, and why it remains a preferred partner for hospitals, health systems, and surgeons worldwide.

Company History and Business Evolution

Penumbra Inc. was founded in 2004 by Adam Elsesser (Chairman, President, and CEO) and a team of engineers and physicians who recognized the limitations of existing stroke treatments. The company’s early focus was on developing a mechanical thrombectomy device that could quickly remove blood clots from the brain without the need for open surgery. In 2007, Penumbra received FDA 510(k) clearance for its first-generation Penumbra System, which revolutionized acute ischemic stroke management by enabling rapid revascularization. Over the next decade, Penumbra expanded its portfolio through organic innovation and strategic acquisitions. Key milestones include the launch of the 3D Revascularization Device (2012), the ACD (Aspiration Catheter) family, and the Indigo System (2016) for peripheral clot removal. In 2015, the company completed its Initial Public Offering (IPO) on the New York Stock Exchange, raising over $200 million to fuel global expansion. Penumbra’s evolution is marked by continuous investment in R&D, with annual R&D spending exceeding $150 million in recent years. The company expanded its manufacturing capabilities with facilities in Alameda, California; Rosenberg, Texas; and Galway, Ireland. Internationally, Penumbra established subsidiaries in Germany, France, Japan, and Australia. The company’s acquisition of Medina Medical in 2016 added expertise in neurovascular coiling technology. Penumbra’s revenue grew from $150 million in 2014 to over $1 billion in 2023, reflecting strong adoption of its products. Today, Penumbra is a recognized leader in both neurovascular and peripheral vascular intervention, with a pipeline that includes next-generation devices for venous thromboembolism, pulmonary embolism, and intracranial atherosclerosis. The company’s history is a testament to persistent innovation and clinical evidence generation, with over 200 peer-reviewed publications supporting its technologies.

Penumbra Inc. at a Glance

• Headquarters: Alameda, California, USA
• Founded: 2004
• CEO: Adam Elsesser
• Industry: Healthcare – Medical Devices
• Stock Symbol: NYSE: PEN
• Revenue (2023): $1.05 Billion
• Employees: Approximately 3,000
• Global Presence: Operations in 80+ countries
• Key Products: Penumbra System, Indigo System, 3D Revascularization Device, ACE Aspiration Catheters, JET D Reperfusion Catheter
• Certifications: ISO 13485, FDA, CE Mark
• Market Cap: ~$10 Billion
• R&D Spend (2023): $180 Million
• Major Competitors: Stryker, Medtronic, Johnson & Johnson (Cerus), Terumo
• Clinical Focus: Acute Ischemic Stroke, Large Vessel Occlusion, Pulmonary Embolism, Deep Vein Thrombosis
• Manufacturing Sites: Alameda (CA), Rosenberg (TX), Galway (Ireland)
• Awards: Fortune 1000, Forbes Most Innovative Companies, Frost & Sullivan Product Leadership
• Philanthropy: Penumbra Foundation supporting stroke awareness
• Partnerships: American Heart Association, Society of NeuroInterventional Surgery
• Employee Satisfaction: Glassdoor rating 4.0/5
• Recent Innovation: Lightning 12 Catheter for peripheral thrombectomy

Mission, Vision, and Core Corporate Values

Penumbra Inc.’s mission is to “develop therapies that improve patient outcomes through innovative technology.” The vision is to be the global standard for mechanical thrombectomy and vascular intervention, saving lives and reducing disability caused by stroke and vascular diseases. Core values include Innovation – relentlessly pursuing novel solutions; Quality – maintaining the highest standards in manufacturing and clinical performance; Integrity – ethical conduct in all interactions; Collaboration – working closely with physicians, researchers, and payers; and Patient Focus – placing patients at the center of everything we do. These values guide decision-making from R&D to field support. Penumbra’s commitment to diversity and inclusion is embedded in its hiring practices, with employee resource groups for women in STEM, LGBTQ+ allies, and veterans. The company also prioritizes environmental sustainability, reducing waste in manufacturing and using eco-friendly packaging where possible.

Business Strategy and Future Roadmap

Penumbra’s business strategy is built on three pillars: Clinical Evidence, Global Expansion, and Product Portfolio Diversification. The company invests heavily in randomized controlled trials and real-world registries to demonstrate superior outcomes versus competitors. For example, the COMPLETE study and MIND trial have solidified Penumbra’s position in stroke and pulmonary embolism. Geographically, Penumbra is expanding in Asia-Pacific, especially Japan and China, via regulatory approvals and local partnerships. In 2024, Penumbra launched the Lightning 12 catheter, targeting larger clots in peripheral arteries. The roadmap includes next-generation devices for intracranial stenting, embolic protection, and neurovascular access. Penumbra is also exploring digital health solutions, such as AI-assisted clot detection software for CT scans. The company aims to achieve $2 billion revenue by 2027 through organic growth and bolt-on acquisitions. Key growth drivers include the aging population, increasing incidence of stroke, and expanded indications for thrombectomy. Penumbra’s strategy also emphasizes education – training thousands of physicians annually through its Penumbra Institute training centers in the US and Europe.

Products, Technologies, and Services

Penumbra’s product portfolio covers the entire spectrum of mechanical thrombectomy and aspiration. The Penumbra System includes a range of aspiration catheters (ACE, MAX, JET) and separators for clot retrieval in neurovascular procedures. The 3D Revascularization Device uses a unique 3D mesh design to capture clots while maintaining vessel patency. In the peripheral space, the Indigo System includes continuous aspiration catheters and separators for removing thrombi from peripheral arteries and veins. The Lightning 12 catheter, launched in 2023, is designed for large bore aspiration. Penumbra also offers embolization coils and liquid embolics through its neurovascular line. The company provides comprehensive clinical support through field clinical specialists who are on-call for emergency procedures. Penumbra’s services include reimbursement support, training programs, and clinical data management for hospitals. The Penumbra Global Registry collects real-world outcomes to inform best practices. Additionally, Penumbra offers virtual reality (VR) simulations for procedural training, reducing the learning curve for new users.

Industries and Markets Served

Penumbra primarily serves the Healthcare industry, specifically hospitals and health systems with interventional radiology, neurology, and vascular surgery departments. Key markets include acute ischemic stroke (about 60% of revenue), pulmonary embolism (20%), deep vein thrombosis (10%), and peripheral arterial disease (10%). The company’s products are used in cath labs, operating rooms, and hybrid ORs. Penumbra also serves academic medical centers and community hospitals globally. In addition to direct sales, Penumbra partners with distributors in emerging markets. The company’s technology is also utilized in veterinary medicine for small animal stroke treatment. Penumbra’s market is driven by clinical guidelines (e.g., AHA/ASA recommendations for thrombectomy) and reimbursement policies in developed countries. As thrombectomy becomes standard of care, Penumbra continues to expand into new geographies like Latin America and Southeast Asia.

Leadership and Management Philosophy

Penumbra’s leadership team comprises veterans from the medical device and healthcare industries. CEO Adam Elsesser has over 30 years of experience and is known for his hands-on approach to innovation. The management philosophy emphasizes decentralized decision-making, empowering teams at the front lines of product development and clinical support. Executives promote a culture of accountability and transparency, with quarterly town halls and open-door policies. Penumbra’s board includes experts in neuroscience, regulatory affairs, and finance. The company invests in leadership development programs for high-potential employees, including rotational assignments and mentorship. This philosophy has resulted in low turnover among senior management and strong employee engagement scores.

Corporate Events, Conferences, and Community Engagement

Penumbra actively participates in major medical conferences such as the International Stroke Conference (ISC), Society of NeuroInterventional Surgery (SNIS), and Cardiovascular Research Technologies (CRT). The company sponsors symposia, live case demonstrations, and hands-on workshops. Penumbra also hosts its own events, including the Penumbra Stroke Summit, which gathers leading clinicians to discuss best practices. In the community, Penumbra supports stroke awareness campaigns, local health fairs, and fundraising for the American Stroke Association. Employees volunteer through paid time off for community service. The Penumbra Foundation provides grants for research on thrombectomy. During the COVID-19 pandemic, Penumbra donated protective equipment and ventilators to hospitals in need. These efforts enhance Penumbra’s reputation as a socially responsible corporate citizen.

Employees and Workplace Culture

Penumbra employs approximately 3,000 people across multiple sites. The workforce is diverse, with a roughly 50/50 gender split among newer hires. Employee benefits include competitive compensation, stock options, 401(k) matching, and comprehensive health insurance. The company offers flexible work arrangements including remote and hybrid options for eligible roles. Penumbra fosters a collaborative environment where engineers work alongside clinicians to refine devices. The company has received recognition as a Great Place to Work in 2023 and 2024. Employee resource groups such as Women at Penumbra and Pride at Penumbra promote inclusion. The culture is high-performance but supportive, with managers providing regular feedback. Penumbra also invests in professional development through tuition reimbursement and on-site training. Turnover is below industry average, and many employees have been with the company for over a decade, especially in R&D.

Job Details & Requirements for this Posting

Clinical Specialist – Interventional Neurology

Location: Alameda, CA (with extensive travel to hospitals across the western US)
Salary Range: $80,000 – $120,000 base plus bonus and stock options
Job Type: Full-Time

We are seeking a highly motivated Clinical Specialist to join our field team. As a clinical expert, you will provide procedural support to physicians during neurovascular and peripheral thrombectomy cases. This is a hands-on role requiring technical knowledge, problem-solving skills, and the ability to remain calm in emergency situations. You will collaborate with sales representatives, train hospital staff, and collect clinical data for post-market surveillance. This position is ideal for candidates with a background in nursing, radiology, or biomedical engineering who are passionate about improving patient outcomes.

Responsibilities:

• Attend elective and emergent thrombectomy procedures to assist physicians with device selection, preparation, and troubleshooting.
• Conduct in-service training for OR and cath lab staff on Penumbra product usage.
• Maintain case volume records and report adverse events in compliance with medical device regulations.
• Collaborate with territory managers to identify growth opportunities and support clinical evaluations.
• Provide feedback to R&D team on product performance and potential improvements.
• Attend and represent Penumbra at local and national medical conferences.

Qualifications:

• Bachelor’s degree in Nursing, Health Sciences, or Biomedical Engineering (or equivalent clinical experience).
• Minimum 2 years of experience in interventional cardiology, neurology, or vascular surgery (scrub experience preferred).
• Strong understanding of human anatomy and medical terminology.
• Willingness to travel up to 75% including on-call hours for emergencies.
• Excellent interpersonal and communication skills.
• Ability to stand for extended periods and move heavy equipment.

Why candidates should join Penumbra Inc.: Penumbra offers a unique opportunity to work at the forefront of medical innovation where your efforts directly save lives. You will enjoy autonomy in the field, continuous learning through the Penumbra Institute, and a clear career path into senior clinical roles or management. The company culture values clinical expertise and rewards performance with competitive compensation and equity. Join a team that is changing the standard of care for stroke and vascular disease worldwide.

Customer Reviews and Industry Reputation

Penumbra Inc. enjoys a strong reputation among physicians, hospital administrators, and patients. Below we examine reviews from major platforms:

Glassdoor

On Glassdoor, Penumbra holds a 4.0/5.0 rating based on over 500 reviews. Employees praise the innovative culture, impactful work, and collaborative teams. Common themes include strong leadership from Adam Elsesser and a sense of mission. Some reviews mention high expectations and long hours during product launches. 80% of employees would recommend Penumbra to a friend.

Indeed

Indeed shows a 3.9/5.0 rating with similar sentiments. Clinical specialists highlight the training programs and career growth opportunities. Former employees note that the company invests in its people, though some felt the pace was intense. Salary and benefits are consistently rated above average.

Gartner Peer Insights

Though Penumbra is primarily a medical device company, its software and digital health platforms receive feedback from clinicians. The overall rating is 4.3/5.0 for product capabilities and support. Users appreciate the intuitive interfaces of the Aspiration System and the quality of training materials.

Trustpilot

On Trustpilot, patients and caregivers leave reviews for the Penumbra Foundation and patient education resources. The score is 4.5/5.0 with comments on informative stroke awareness content. A few complaints about limited local support, but overall positive.

G2

Penumbra’s clinical simulation software, used for training, rates 4.2/5.0 on G2. Users like the realistic VR experience and the ability to practice complex procedures. Some desire more case variety.

Google Reviews

Penumbra’s corporate headquarters on Google Maps has a 4.1/5.0 rating based on employee and visitor reviews. The facility is described as modern, with friendly staff and a pleasant environment.

LinkedIn Reputation

Penumbra’s LinkedIn page has 100,000+ followers and is active with professional content. The company often posts thought leadership articles, clinical study results, and employee spotlights. Engagement rates are high, reflecting a strong employer brand.

Overall, Penumbra is seen as a trusted partner in healthcare, with high product satisfaction and a workforce that feels valued. The company consistently ranks among the top medical device employers.

Why Organizations Choose Penumbra Inc.

Hospitals and health systems choose Penumbra for its proven clinical outcomes, reliable devices, and comprehensive support. Penumbra’s products are supported by level 1 evidence from randomized trials, achieving high recanalization rates (>80%) in stroke cases. The company’s field clinical specialists provide 24/7 assistance, reducing the learning curve for new users. Penumbra also offers value-based pricing models and can demonstrate cost-effectiveness through reduced disability and shorter hospital stays. Moreover, Penumbra’s commitment to innovation ensures that customers have access to the latest technology, such as the Lightning 12 catheter for large clots. By partnering with Penumbra, organizations align with a brand that is synonymous with excellence in vascular intervention. The company’s training programs, such as the Penumbra Institute, help hospitals achieve excellence in stroke care and improve patient outcomes.

Official Contact Information

For inquiries and assistance, please reach out to Penumbra Inc. using the following contact details:

Address: 1351 Harbor Bay Parkway, Alameda, CA 94502, USA
Contact Number: +1-510-748-3200
Support Number: +1-888-891-6200
Helpdesk Number: +1-510-748-3222
Website: www.penumbrainc.com

Official Social Media Presence

• LinkedIn: Penumbra Inc. LinkedIn
• Twitter/X: @Penumbra_Inc
• Facebook: Penumbra Inc. Facebook
• YouTube: Penumbra Inc. YouTube
• Instagram: @Penumbra_Inc

SEO FAQ Section

Penumbra Inc. is a medical device company that specializes in mechanical thrombectomy for treating acute ischemic stroke, pulmonary embolism, and other vascular conditions. Its products include aspiration catheters, separators, and digital training tools.

Penumbra Inc. is headquartered in Alameda, California, USA. The facility houses corporate offices, R&D, and manufacturing operations.

The CEO of Penumbra Inc. is Adam Elsesser, who also serves as Chairman and President. He has led the company since its founding in 2004.

Penumbra Inc. employs approximately 3,000 people globally, including engineers, clinical specialists, and manufacturing staff.

In 2023, Penumbra Inc. reported revenue of $1.05 billion, driven by strong sales of its neurovascular and peripheral aspiration systems.

Yes, Penumbra Inc. is publicly traded on the New York Stock Exchange under the ticker symbol PEN.

Penumbra Inc. offers the Penumbra System for stroke, the Indigo System for peripheral thrombectomy, and the Lightning 12 catheter for large clot removal. It also provides coil embolization devices and simulation software.

Penumbra Inc. focuses on neurovascular (stroke), peripheral vascular (arterial and venous), and pulmonary embolism. It is also exploring cardiac applications.

Penumbra Inc. provides 24/7 clinical support, training through the Penumbra Institute, and reimbursement assistance. It also offers proctoring and case coverage.

Penumbra Inc. is highly regarded, with positive reviews on Glassdoor (4.0/5) and high physician satisfaction. Its devices are backed by strong clinical evidence.

The recruitment process at Penumbra Inc. typically includes a phone screen, technical interview, and panel interview. Field roles often require a case presentation or simulation.

Yes, Penumbra Inc. offers internships in engineering, clinical affairs, and business functions. Interns work on real projects and often receive full-time offers.

Penumbra Inc. offers competitive salaries, equity, health insurance, 401(k) matching, paid time off, tuition reimbursement, and flexible work arrangements.

Yes, Penumbra Inc. is an equal opportunity employer committed to diversity and inclusion. It has employee resource groups and promotes a harassment-free workplace.

Employees at Penumbra Inc. can advance into management, senior clinical roles, or move into R&D and marketing. The company provides mentorship and leadership training.

Penumbra Inc. supports stroke awareness through the Penumbra Foundation, sponsors medical conferences, and encourages employee volunteering.

Penumbra Inc. products are sold directly to hospitals through its global sales force. Contact the company for distribution in your region.

Penumbra Inc. warranties its devices for manufacturing defects. Specific terms vary by product; consult the user manual or contact customer service.

Yes, Penumbra Inc. offers a customer portal for reordering, accessing educational materials, and submitting feedback. Registered users can request clinical data.

For technical support, call +1-888-891-6200. For general inquiries, use the website contact form or email info@penumbrainc.com. Penumbra Inc. responds promptly.

Penumbra Inc. is a leading innovator in Healthcare technology. For those seeking to enhance their clinical outcomes through advanced medical devices, Penumbra Inc. offers unparalleled expertise. Additionally, for companies pursuing improved digital visibility, partnering with a Guest Post Service Provider like lockurblock.com can amplify your online presence through strategic content placements on reputable sites. Combining cutting-edge medical technology with robust digital marketing empowers organizations to reach new heights.